Ness Ziona, Israel, and San Diego, September 15, 2016 – NRGene, a globally recognized leader in genomic analysis, announced today that Novogene, a leading global provider of genomic services and solutions, will further enhance its strong genomic analysis capabilities by including NRGene’s DeNovoMAGICTM-2.0 and PanMAGICTM solutions in its service offerings.

“As an industry leader in de novo sequencing and assembly, Novogene is pleased to announce the addition of NRGene’s technologies,” said Dr. Ruiqiang Li, founder and chief executive officer of Novogene. “These solutions complement our existing expertise and SOAPdenovo and NovoHeter software for complex genome assembly, and will provide our customers with even more detailed biological understanding from genomic data analysis.”

With NRGene’s DeNovoMAGICTM-2.0, Novogene’s customers will receive complete, highly accurate genome assemblies in the form of long, phased sequences. NRGene’s PanMAGICTM compares the complete genome sequences of multiple individuals to capture the broad genomic diversity within a pan-genomic view.

NRGene’s recent breakthroughs on the full genome assemblies of multiple wheat species, maize, soybeans, and many other key crops are already impacting the research of scientists and plant breeders seeking to create more productive and hardier varieties of the plants the world most depends on for its nutritional needs.

“The agreement with Novogene is a significant achievement toward our goal of supporting the Chinese agriculture research community,” says NRGene CEO Gil Ronen. “Since China needs to feed 20% of the world’s population using only 10% of the world’s cultivated land, it’s critical that its scientists have access to the best tools to quickly breed new farm animals and more productive seed varieties. The agreement with Novogene helps accelerate that process, as Novogene already supports the genetic research of thousands of institutions across China and the globe with the world’s largest sequencing capacity and innovative data analysis solutions.”

About Novogene

Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and one of the largest sequencing capacities in the world. Novogene utilizes scientific excellence, a commitment to customer service and unsurpassed data quality to help our clients realize their research goals in the rapidly evolving world of genomics. Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world-leader in NGS services, Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world-leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 32 NGS-related patents, as well as over 580 research papers with total impact factor at more than 4090, including publications in first tiers journals such as Cell, Nature and Science. For more information, please visit our website: novogene.com/amea-en

About About NRGene

NRGene is a genomic big data company developing cutting-edge software and algorithms to reveal the complexity and diversity of crop plants, animals, and aquatic organisms for supporting the most advanced and sophisticated breeding programs. NRGene tools have already been employed by some of the leading seed companies worldwide as well as the most influential research teams in academia. www.nrgene.com

Novogene Contact

Joyce Peng, Ph.D. General Manager and Global Marketing Director Novogene Corporation +1-626-222-5584 joyce.peng@novogene.com novogene.com/amea-en

NRGene Contact

Amy Kenigsberg K2 Global Communications +1-913-440-4072 (+7 ET) +972-9-794-1681 (+2 GMT) amy@k2-gc.com